About
Partnering
Responsibility
People and Culture
News
Contact
Change Language

News

Refine by category
Refine by year
- 2020
- 2019
- 2018
- Archive

Investors —

Corporate Presentation

10 Jun 2019

Find here our corporate presentation with information relating to etc ...
Learn more
Investors —

Update on the Recapitalization Transaction

13 Aug 2018

Update on the implementation of Concordia's recapitalization transaction.
Learn more
Investors —

Concordia International corp. announces second quarter 2018 results

08 Aug 2018

Update On Concordia's Recently Completed Recapitalization
Learn more
Investors —

Concordia International corp. announces release date for second quarter 2018 results

25 Jul 2018

Concordia International Corp. Announces Second Quarter 2018 Results
Learn more
Investors —

Concordia International corp. announces release date for second quarter 2018 results

25 Jul 2018

Update on Concordia's Recapitalization Transaction
Learn more
Investors —

Concordia International corp. announces NASDAQ delisting

19 Jul 2018

Concordia Completes Recapitalization Transaction
Learn more

Featured News

Get up-to-date news direct to your inbox.

Name

Email

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 20
Learn more
Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors

17 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

04 Jan 2019

Company acquires international rights to Salagen® tablets (pilocarpine hydrochloride) (excluding Japan ri
Learn more

About
Responsibility
People and Culture
News
Contact

Terms and Conditions
Privacy Policy
Recruitment Scams
Information Sources

Copyright 2020 Abcur English®. All Rights Reserved